Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition
- 期刊名称The American Journal of Clinical Nutrition
- 作者Brown, M R; Cohen, H J; Lyons, J M; Curtis, T W; Thunberg, B; Cochran, W J; Klish, W J
- 卷第43卷
- 期第4期
- 印刷ISSN0002-9165
- 电子ISSN1938-3207
- 文件大小923.43KB
- 发表时间1986-04-01
- DOI10.1093/ajcn/43.4.549
- 页码549-554
IRBESARTAN/AMLODIPINE FIXED COMBINATION IN PATIENTS UNCONTROLLED ON IRBESARTAN 150 MG (1-ADD STUDY)Bobrie, G. · Journal of Hypertension · 2011
Cardioprotective effects of irbesartan in polymicrobial sepsis; Kardioprotektive Wirkungen von Irbesartan bei polymikrobieller Sepsis;Yousif, N. G.; Hadi, N. R.; Al-Amran, F.; Zigam, Q. A. · Herz · 2017
Effect of Irbesartan Versus Atenolol on Left Ventricular Mass and Voltage: Results of the CardioVascular Irbesartan ProjectSchneider, M. P.; Klingbeil, A. U.; Delles, C.; Ludwig, M.; Kolloch, R. E.; Krekler, M.; Stumpe, K. O.; Schmieder, R. E. · Hypertension · 2004
Hydrophilic interaction chromatography-tandem mass spectrometric analysis of irbesartan in human plasma: Application to pharmacokinetic study of irbesartanHye Won Lee; Hye Young Ji; Eun-Seok Park; Kang Choon Lee; Hye Suk Lee · 2009
The efficacy and safety of irbesartan/HCTZ 150/12.5 mg and irbesartan/HCTZ 300/25 mg in patients with hypertension uncontrolled on monotherapyJoel M. Neutel; Elijah Saunders · 2005
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy TrialHunsicker, Lawrence G.; Atkins, Robert C.; Lewis, Julia B.; Braden, Gregory; de Crespigny, Paul J. Champion; DeFerrari, Giacomo; Drury, Paul; Locatelli, Francesco; Wiegmann, Thomas B.; Lewis, Edmund J. · Kidney International · 2004
[PS 01-29] COMBINATION IRBESARTAN/AMLODIPINE VERSUS IRBESARTAN/CILNIDIPINE FOR ATTENUATION OF ALBUMINURIA IN RATS WITH STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHYSatoh, Minoru; Nishi, Yuko; Kadoya, Hiroyuki; Itano, Seiji; Komai, Norio; Sasaki, Tamaki; Kashihara, Naoki · Journal of Hypertension · 2016
Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy TrialEvans, M.; Bain, S. C.; Hogan, S.; Bilous, R. W. · Nephrology Dialysis Transplantation · 2012
AtorvastatinKatherine F. Croom, Greg L. Plosker · 2005
SulfasalazineGreg L. Plosker, Katherine F. Croom · 2005
EscitalopramKatherine F. Croom,Greg L. Plosker · PharmacoEconomics · 2003
EplerenoneKatherine F. Croom,Greg L. Plosker · PharmacoEconomics · 2005
MirtazapineKatherine F. Croom,Caroline M. Perry,Greg L. Plosker · CNS Drugs · 2009